The features of clinical course and complexities in the diagnosis of a case of epithelioid trophoblastic disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Epithelioid trophoblastic tumor was first described by morphologists in 1995; the world literature reports only about 90 cases of this tumor, which confirms its extreme rarity. This type of tumor is characterized by high malignancy and fairly rapid distant metastasis. At the same time, the current chemotherapy regimens, even those for distant metastases, show a good sufficient efficiency. Clinical case report. The paper analyzes the features of clinical course, diagnostic difficulties, and the observation in epithelioid tumor. It presents difficulties in the interpretation of clinical data and in the differential diagnosis of morphological features in this type of tumor. The authors show the expediency and high informative value of immunohistochemical examination of a tissue specimen. Conclusion. This category of patients should be examined and treated in specialized clinics that have a possibility to perform combined treatment and positive experiences in treating patients with trophoblastic tumors.

Full Text

Restricted Access

About the authors

Alyona L. Chernyshova

Research Institute of Oncology, Tomsk National Research Medical Center

Email: alacher@list.ru
MD, professor of RAS, leading researcher, Gynecology Department, Cancer Research Institute

Larisa A. Kolomiets

Research Institute of Oncology, Tomsk National Research Medical Center

Email: kolomietsla@oncology.ru
MD, professor, head of Gynecology Department, Cancer Research Institute

Anastasia Yu. Kishkina

Research Institute of Oncology, Tomsk National Research Medical Center

postgraduate, Gynecology Department, Cancer Research Institute

Maxim O. Ochirov

Research Institute of Oncology, Tomsk National Research Medical Center

postgraduate, Gynecology Department, Cancer Research Institute

Svetlana A. Glushchenko

Research Institute of Oncology, Tomsk National Research Medical Center

PhD, doctor of the Department of Pathomorphology, Cancer Research Institute

Vladimir M. Perelmuter

Research Institute of Oncology, Tomsk National Research Medical Center

Email: perelmuter@oncology.ru
MD, professor, head of the Department of Pathomorphology, Cancer Research Institute

References

  1. Materials of the 17th International Meeting of the European Society of Gynaecological Oncology (ESGO). Milan; 2011.
  2. Goglia U., Vinanzi C., Zuccarello D., Malpassi D., Ameri P., Casu M. et al. Identification of a novel mutation in exon 1 of the androgen receptor gene in an azoospermic patient with mild androgen insensitivity syndrome: case report and literature review. Fertil. Steril. 2011; 96(5): 1165-9.
  3. Consuelo L., Lopes V.S., Rodrigues F.R., Steim J.L. Gestational trophoblastic neoplasia after ectopic molar pregnancy: clinical, diagnostic, and therapeutic aspects CC BY-NC-ND 4.0. Rev. Bras. Ginecol. Obstet. 2018; 40(05): 294-9. doi: 10.1055/s-0038-1653976.
  4. Lei W., Zhang F., Zheng C., Zhao C., Tu S., Bao Y. Metastatic epithelioid trophoblastic tumor of the lung: A case report. Medicine (Baltimore). 2018; 97(16): e0306. DOI: 10.1097 / MD.0000000000010306
  5. Cools M., Wolffenbuttel K.P., Hersmus R., Mendonca B.B., Kaprovd J., Drop S.L. et al. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling. Hum. Reprod. 2017; 32(12): 2561-73. doi: 10.1093/humrep/dex300.
  6. Yunusova N.V., Kondakova I.V., Kolomiets L.A., Afanas’ev S.G., Chernyshova A.L., Kudryavtsev I.V., Tsydenova A.A. Molecular targets for the therapy of cancer associated with metabolic syndrome (transcription and growth factors). Asia Pac. J. Clin. Oncol. 2018; 14(3): 134-40. doi: 10.1111/ajco.1278
  7. Спирина Л.В., Бочкарева Н.В., Кондакова И.В., Коломиец Л.А., Шашова Е.Е., Коваль В.Д., Чернышова А.Л., Асадчикова О.Н. Регуляция инсулиноподобных факторов роста и NF- B. протеасомной системой при раке эндометрия. Молекулярная биология. 2012; 46(3): 452-60.
  8. Gottlieb B., Beitel L.K., Nadarajah A., Paliouras M., Trifiro M. The androgen receptor gene mutations database (ARDB): 2012 update. Hum. Mutat. 2012; 33(5): 887-94.
  9. Кондакова И.В., Спирина Л.В., Коваль В.Д., Шашова Е.Е., Чойнзонов Е.Л., Иванова Э.В., Коломиец Л.А., Чернышова А.Л., Слонимская Е.М., Усынин Е.А., Афанасьев С.Г. Имотрипсинподобная активность и субъединичный состав проееасом в злокачественных опухолях человека. Молекулярная биология. 2014; 48(3): 444-51.
  10. Zhao J.R., Cheng W.W., Wang Y.X., Cai M., Wu W.B., Zhang H.J. Identification of microRNA signature in the progression of gestational trophoblastic disease. Cell Death Dis. 2018; 9(2): 94.
  11. FIGO Committee on Gynaecologic Oncology. Int. J. Gynaecol. Obstet. 2009; 105: 103-4.
  12. Materials of the 13th Biennial Meeting of the International of Gynecologic Cancer Society (IGCS). Prague; 2010.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2019 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies